StockData
Invivyd, Inc. logo

Invivyd, Inc. (IVVD) stock

IVVDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3045% below fair value
$0.51−0.03 (-4.67%)

Close on Nov 17, 2026Market cap $151.09MP/E –Yield –

Invivyd operating margin

Operating margin is operating income as a percentage of revenue.

Invivyd's operating margin for the twelve months ending Jun 30, 2026 was -192.8%. For fiscal 2025 it was -104.0%, against -696.8% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-104.0%+592.8
FY2024Dec 31, 2024-696.8%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-320.8%−193.0
Q1 FY2026Mar 31, 2026-313.9%−164.2
Q4 FY2025Dec 31, 2025-73.0%+66.2
Q3 FY2025Sep 30, 2025-84.0%+586.1
Q2 FY2025Jun 30, 2025-127.8%+2047.4
Q1 FY2025Mar 31, 2025-149.7%–
Q4 FY2024Dec 31, 2024-139.1%–
Q3 FY2024Sep 30, 2024-670.0%–
Q2 FY2024Jun 30, 2024-2175.2%–

More Invivyd figures

See a number that looks wrong?